2-methyl-4-carboxyphenylglycine,
alpha-MCPG,
alpha-methyl-4-carboxyphenylglycine,
alpha-methyl-CPGly,
LY-367385,
LY367385,
LY 367385,
198419-91-9,
LY367385,
LY-367385,
UNII-D8UW47H17B,
LY-367385 hydrochloride,
CHEMBL94631,
D8UW47H17B,
4-[(S)-amino(carboxy)methyl]-3-methylbenzoic acid,
(S)-(+)-a-amino-4-carboxy-2-methylbenzeneacetic acid,
4-[(1S)-1-amino-2-hydroxy-2-oxoethyl]-3-methylbenzoic acid,
Benzeneacetic acid, alpha-amino-4-carboxy-2-methyl-, (alphaS)-,
AC1NSKBK,
Tocris-1237,
SCHEMBL661700,
GTPL1379,
ZINC6978,
DTXSID2042563,
SGIKDIUCJAUSRD-QMMMGPOBSA-N,
BDBM50084140,
MFCD02262124,
PDSP1_001314,
PDSP2_001298,
(+)-2-methyl-4-carboxyphenylglycine,
AKOS015923884,
NCGC00025067-01,
NCGC00025067-02,
ACM198419919,
(S)-2-(4-Carboxy-2-methylphenyl)glycine,
B6649,
LY-367385 hydrochloride, >=98% (HPLC),
SR-01000597418,
(S)-4-(amino(carboxy)methyl)-3-methylbenzoic acid,
J-012816,
SR-01000597418-1,
4-((S)-Amino-carboxy-methyl)-3-methyl-benzoic acid,
Benzeneacetic acid,a-amino-4-carboxy-2-methyl-,(as)-,
(S)-(+)-?-Amino-4-carboxy-2-methylbenzeneacetic acid,
(R)-(+)-alpha-Amino-4-carboxy-2-methylbenzeneacetic acid,
(s)-(+)-alpha-amino-4-carboxy-2-methylbenzeneacetic acid,
Benzeneacetic acid, alpha-amino-4-carboxy-2-methyl-, (S)-,
alpha-Mcpg,
alpha-Methyl-cpgly,
D04JQR,
2-methyl-4-carboxyphenylglycine,
L-367385 analogs, Lilly,
alpha-Methyl-4-carboxyphenylglycine,
Metabotropic mGluR1 agonists, Lilly,
CID5311261,